Nonsteroidal aldosterone antagonism with finerenone had a strong trend toward reduced AF incidence in patients with HFpEF [ 47 ], consistent with pooled analysis from the larger investigative program incorporating patients with chronic kidney disease and diabetes mellitus [ 48 ].
← all excerpts
Left Atrial Dysfunction in Patients with Atrial Fibrillation and Heart Failure.
1
—
—